Conclusion WHO schema can be well applied to instruct clinical treatment and predict prognosis of thymoma .

结论WHO 胸腺瘤组织 分 型方案能较好地指导临床治疗和判断预后，有 较高 的 临床应用价值。

Correlation of VEGF expression and microvessel density with spiral CT manifestations of thymoma

胸腺瘤中VEGF的表达及微血管密度与其 胸腺瘤螺旋CT表现的相关性

Objective To explore the significance of P53 protein expression in different type of thymoma .

目的探讨P53的表达在不同类型 胸腺瘤中的意义。

Thymus pathology showed lymphoid hyperplasia 12 cases normal 7 cases no thymoma found .

胸腺病理检查：增生12例，正常组织学表现7例，无 合并 胸腺瘤者。

Objective To study the clinical characteristics of myasthenia gravis ( MG ) with thymoma .

目的研究 伴 胸腺瘤重症肌无力的临床特点。

Evaluation of surgical treatment of 32 myasthenia gravis patients with thymoma

32例重症肌无力 伴 胸腺瘤患者手术治疗疗效评价

Comparative study on spiral CT imaging and WHO pathological typing of thymoma

胸腺瘤螺旋CT表现与其WHO病理分型对照研究

Of these patients 19 patients were non-small-cell lung cancer 10 patients were invasive thymoma .

其中非小细胞肺癌19例、浸润性 胸腺瘤10例。

Objective To analyze the characteristics of operation and the prognosis in 96 patients with thymoma .

目的对96例 胸腺瘤进行 临床分析，了解胸腺瘤手术与分期、预后的关系。

Clinical analysis of myasthenia crisis after thymectomy in patients with thymoma and myasthenia gravis

胸腺瘤 伴重症肌无力患者术后肌无力危象的临床分析

Objective To review and summarize 26 cases of thymoma underwent surgical treatment .

目的回顾总结26例 胸腺瘤外科治疗经验。

Chemotherapy Efficacy and Prognostic Factors Analysis of 72 Patients with Malignant Thymoma

72例恶性 胸腺瘤的化疗疗效和预后因素分析

Objective To enhance the operation security and the cure rate of the myasthenia gravis patients with thymoma or thymus hyperplasia and to sum up the clinical experience .

目的提高重症肌无力 合并胸腺增生或 胸腺瘤患者手术的安全性和治愈率，总结其临床经验。

Pathological Features and Surgical Effect of Invasive Thymoma

侵袭性 胸腺瘤的病理特征及手术治疗效果观察

Objective : To improve the understanding of erythrocytosis associated with malignant thymoma .

合并红细胞增多症的认识。

Analysis on the Relationship between the Pathology of Thymoma and Myasthenia Gravis

胸腺瘤病理 分 型与重症肌无力相关性分析

Dimensional Conformal Radiotherapy Combined with Chemotherapy for Thymoma

浸润 型 胸腺瘤三维适形放射治疗联合同步化疗的疗效观察

MRI Appearances of Thymoma and Correlation Study with Histo-pathology

胸腺瘤MRI表现与其组织病理学分型的相关研究

Diagnosis treatment and prognosis of thymoma : analysis of 116 cases

胸腺瘤的诊断、治疗和预后

Thymoma with the first symptom of chronic diarrhea

以慢性腹泻为首发症状的 胸腺瘤 的 探讨

The Significance of the Apoptosis-associated Genes in Thymoma Tissue from Patients with Myasthenia Gravis

凋亡相关基因在 胸腺瘤 合并重症肌无力患者病因研究中的意义

Objective To explore the mechanism of human serum complement induced murine thymoma EL-4 cell lysis and to construct the complement non-lethal attack model on T lymphocytes .

目的探讨人血清补体杀伤小鼠 胸腺瘤EL-4细胞的机制，建立补体杀伤T淋巴细胞的非致死模型。

WHO Histologic Classification of Thymoma and its Relationship with Thymoma Diagnosis and Treatment Thymus : Pyramid-shaped lymphoid organ ( see lymphoid tissue ) Between the Breastbone and the heart .

胸腺瘤WHO组织学分型与胸腺瘤诊治的关系胸腺：胸骨与心脏之间的角锥形的淋巴器官。

Surgical Management and Prognosis Analyze of Thymoma Invading the Great Vessels

恶性 胸腺瘤侵犯大血管的手术治疗及术 后生存 调查

Conclusion It was accurate to using spiral CT to differentiate the invasive from noninvasive thymoma .

结论螺旋CT对 胸腺瘤侵袭性与非侵袭性的诊断有较高的准确性。

Pertinence between the Expression of Fas and Bcl-2 in Tissue of Thymoma Patient and Being Complicated by Myasthenia Gravis

生物Fas和Bcl-2在 胸腺瘤患者 瘤组织表达中与并发重症肌无力的相关性研究

The pathogenesis related to the erythropoietin secretion from malignant tumors while another factor might be the immunological disturbance of T-lymphocyte caused by thymoma .

其发病机制与恶性肿瘤分泌促红细胞生成素有关，也可能是 胸腺瘤所致T细胞免疫功能紊乱所致。

Eight cases of myasthenia gravis with thymoma treated with steroid therapy combined with thymus irradiation are reported .

本文报告用类固醇与胸腺放射联合治疗8例 伴 胸腺瘤的重症肌无力。

Surgical Treatment and Prognostic Analysis in Patients with Malignant Thymoma

恶性 胸腺瘤患者手术疗效及其预后因素分析